Pharma Business Week articles from August 2004

Pharma Business Week archives from August 2004

CombiMatrix announces human drug metabolism array.
August 2, 2004... 2004 AUG 2 - (NewsRx.com & NewsRx.net) -- Acacia Research Corp.'s (CBMX) CombiMatrix group has made available to researchers a new CustomArray Human Drug Metabolism Array. This array enables researchers to screen a panel of genes and...

Chiron acquires San Diego company.
August 2, 2004... 2004 AUG 2 - (NewsRx.com & NewsRx.net) -- Chiron Corp. (CHIR) and Sagres Discovery announced that Chiron has acquired Sagres. Sagres, a privately held company headquartered in Davis, California, focuses on the discovery and validation of...

Company receives license for new meningococcal B vaccine for New Zealand.
August 2, 2004... 2004 AUG 2 - (NewsRx.com & NewsRx.net) -- Chiron Corp. (CHIR) has received a license for its new meningococcal B vaccine for New Zealand, MeNZB. Chiron developed the vaccine, in close collaboration with the New Zealand Ministry of Health...

FDA approval granted for Aldara for superficial basal cell carcinoma.
August 2, 2004... 2004 AUG 2 - (NewsRx.com & NewsRx.net) -- 3M announced that the U.S. Food and Drug Administration (FDA) has approved the first prescription therapy in nearly a decade for the treatment of superficial basal cell carcinoma (sBCC), a type of...

FDA approves phase III study design for PreHistin.
August 2, 2004... 2004 AUG 2 - (NewsRx.com & NewsRx.net) -- BioGentech Corp. (BGTH) has received a letter from the U.S. Food and Drug Administration (FDA) in which the FDA confirmed that two phase III study designs submitted by BioGentech for review effectively...

Tentative approval granted for Allegra-D extended-release tablets.
August 2, 2004... 2004 AUG 2 - (NewsRx.com & NewsRx.net) -- Barr Pharmaceuticals, Inc., (BRL) announced that Barr Laboratories, Inc., has received tentative approval from the U.S. Food and Drug Administration (FDA) for its generic version of Aventis...

Enrollment closes in phase III trial with Phenserine.
August 2, 2004... 2004 AUG 2 - (NewsRx.com & NewsRx.net) -- Axonyx, Inc., (AXYX) announced that it has completed enrollment in the first of its two on-going phase III clinical studies evaluating Phenserine in patients with mild to moderate Alzheimer disease. ...

Alsin is a Rab5 and Rac1 guanine nucleotide exchange factor.
August 2, 2004... 2004 AUG 2 - (NewsRx.com & NewsRx.net) -- Researchers have found that a large protein, alsin, is a Rab5 and Rac1 guanine nucleotide exchange factor, and may play a role in a juvenile form of amyotrophic lateral sclerosis. "ALS2 is the gene...

Agreement with FDA reached on clinical development program for diltiazem.
August 2, 2004... 2004 AUG 2 - (NewsRx.com & NewsRx.net) -- DOV Pharmaceutical, Inc., (DOVP) has reached agreement with the FDA's (U.S. Food and Drug Administration) Cardio-Renal Division on the scope and design of the clinical trials required for submission of...

Styrylquinolines do not interfere with HIV entry but act before integration.
August 2, 2004... 2004 AUG 2 - (NewsRx.com & NewsRx.net) -- SQLs do not interfere with HIV entry but act before integration. According to a study from France, "We have previously shown that styrylquinolines (SQLs) are integrase inhibitors in vitro. They...

New methods ease the separation of antisense oligonucleotide in plasma.
August 2, 2004... 2004 AUG 2 - (NewsRx.com & NewsRx.net) -- New methods ease the separation of antisense oligonucleotide in plasma. "A novel approach is presented for the direct injection, and subsequent separation, of antisense phosphorothioate...

Hundreds of athletes with asthma compete in Athens.
August 2, 2004... 2004 AUG 2 - (NewsRx.com & NewsRx.net) -- A diagnosis of asthma used to mean a seat on the bench for amateur and professional athletes. But with advances in asthma treatment and management, asthma - not the athlete - is sent to the...

Oxidized lipids, antibodies may be markers for atherogenesis.
August 2, 2004... 2004 AUG 2 - (NewsRx.com & NewsRx.net) -- The oxidation hypothesis of atherogenesis has been studied and researchers report new evidence that oxidized lipids and antibodies in those lipids may play a role as markers for atherogenesis. "The...

U.S. pharmacy group to distribute nutritional supplement.
August 2, 2004... 2004 AUG 2 - (NewsRx.com & NewsRx.net) -- Australian Cancer Technology Limited (ACU) announced that its U.S. subsidiary, ACT (USA), has signed a distribution deal with Rochester Drug Cooperative, which will see the revisys range of nutritional...

Pharmaceutical innovation award program announced.
August 2, 2004... 2004 AUG 2 - (NewsRx.com & NewsRx.net) -- Microsoft Corp. (MSFT) announced the first Microsoft Pharmaceutical Innovation Award program, sponsored by Proscape Technologies Inc. Through this annual award, Microsoft will recognize the...

Imaging agent launched for preclinical computed tomography.
August 2, 2004... 2004 AUG 2 - (NewsRx.com & NewsRx.net) -- Alerion Biomedical, Inc., a company developing diagnostic and therapeutic products based on its molecular targeting technologies, has launched Fenestra, its first contrast enhancement product line for...

Cancer therapeutics development company files IND for metastatic breast cancer.
August 2, 2004... 2004 AUG 2 - (NewsRx.com & NewsRx.net) -- NeoRx Corporation (Nasdaq:NERX) announced that it has filed an Investigational New Drug (IND) application with the U.S. Food and Drug Administration (FDA) for a phase II clinical study of STR (skeletal...

Medical technology company lists on London AIM Exchange, reports on options.
August 2, 2004... 2004 AUG 2 - (NewsRx.com & NewsRx.net) -- Norwood Abbey Ltd. (OTC:NABYF) (ASX:NAL) advises that the securities of its subsidiary Norwood Immunology Ltd (NIM) have commenced trading on London's Alternative Investment Market (AIM:NIM). The...

Personal care products marketer applies for NASDAQ national market listing.
August 2, 2004... 2004 AUG 2 - (NewsRx.com & NewsRx.net) -- Natural Health Trends Corp. (OTC BB: NHLC) announced that it filed an application during the second quarter of 2004 to list the company's common stock on the NASDAQ National Market System. Mark...

Pharma company announces exercise of over allotment option.
August 2, 2004... 2004 AUG 2 - (NewsRx.com & NewsRx.net) -- Pharmion Corporation (NASDAQ:PHRM) announced that the underwriters of its previously announced offering of common stock have exercised in full their over allotment option and agreed to purchase an...

Pharmaceutical company added to Russell 2000 Index.
August 2, 2004... 2004 AUG 2 - (NewsRx.com & NewsRx.net) -- Pharmos Corporation (NASDAQ:PARS) announced that the company has been added to the Russell 2000 Index, a subset of the Russell 3000 Index. The Russell 3000 comprises 3,000 of the largest U.S....

Pharmaceutical group announces that joint venture is operational.
August 2, 2004... 2004 AUG 2 - (NewsRx.com & NewsRx.net) -- Hubei Pharmaceutical Group (HBEI) announced that its new joint venture, a 60% controlling interest in Hubei Tongji Benda Ebei Pharmaceutical Co. Ltd. (HBBendaJV), located in Guangshui City, Hubei...

Alprox-TD license, supply and distribution agreement signed with Schering.
August 2, 2004... 2004 AUG 2 - (NewsRx.com & NewsRx.net) -- NexMed, Inc., (NASDAQ:NEXM) announced that it has entered into a license, supply and distribution agreement with Schering AG, Germany (NYSE: SHR; FSE: SCH). This agreement provides Schering with...

Approval received to market Lyrica in Europe.
August 2, 2004... 2004 AUG 2 - (NewsRx.com & NewsRx.net) -- Pfizer Inc said that it has received approval from the European Commission to market Lyrica (pregabalin) in all European Union member states for the treatment of peripheral neuropathic pain and as an...

Biopharmaceutical company announces contract with GlaxoSmithKline.
August 2, 2004... 2004 AUG 2 - (NewsRx.com & NewsRx.net) -- ProMetic Life Sciences Inc. (TSX: PLI) announced that its wholly owned subsidiary ProMetic BioSciences Ltd. has signed a contract with GlaxoSmithKline (GSK) to provide GSK access to ProMetic's unique...

Biosafety lab expansion, patent issuance and biodefense reagents sale announced.
August 2, 2004... 2004 AUG 2 - (NewsRx.com & NewsRx.net) -- Commonwealth Biotechnologies, Inc., (NASDAQ: CBTE) announced completion of its new virology biosafety level 3 laboratory within its accredited BSL-3 suite. Construction and fit-out of the new lab...

Biotech firm establishes new international headquarters.
August 2, 2004... 2004 AUG 2 - (NewsRx.com & NewsRx.net) -- Biogen Idec (BIIB) officially opened its new international headquarters in Zug, Switzerland. With its global commercial and administrative operations headquartered in Switzerland, Biogen Idec will...

Certificate of Suitability granted for Cephradine.
August 2, 2004... 2004 AUG 2 - (NewsRx.com & NewsRx.net) -- Orchid Chemicals & Pharmaceuticals Ltd. (Orchid) announced that it has been granted the Certificate of Suitability (CoS) by the European Directorate for the Quality of Medicines (EDQM) for its API...

Drug discovery company spins off peptide technologies business unit.
August 2, 2004... 2004 AUG 2 - (NewsRx.com & NewsRx.net) -- Jerini AG has transferred its peptide technologies business unit to a wholly owned subsidiary to ensure further growth and increased market penetration. Under the direction of former business unit...

FDA approval granted for new biopharmaceutical production plant.
August 2, 2004... 2004 AUG 2 - (NewsRx.com & NewsRx.net) -- Boehringer Ingelheim has received official approval for its new biopharmaceutical active ingredients production plant following an inspection of the plant at the Biberach (Riss) site by the U.S. Food...

First payment made in Therapik multi-year agreement.
August 2, 2004... 2004 AUG 2 - (NewsRx.com & NewsRx.net) -- The Jenex Corporation (JEN) has received their first payment of $77,500 from the previously announced exclusive multi-year agreement with Daeyang E&C of Korea. Daeyang will manufacture and market...

Licensing agreement forged for antiphospholipid therapy technology.
August 2, 2004... 2004 AUG 2 - (NewsRx.com & NewsRx.net) -- Peregrine Pharmaceuticals (NASDAQ:PPHM) announced that it has completed a worldwide exclusive licensing agreement for intellectual property related to anti- phosphatidylserine (anti-PS) antibodies. ...

Ligand announces $1 million milestone payment.
August 2, 2004... 2004 AUG 2 - (NewsRx.com & NewsRx.net) -- Ligand Pharmaceuticals Incorporated (LGND) announced that TAP Pharmaceutical Products Inc. has selected an additional selective androgen receptor modulator (SARM) as a second clinical candidate for...

London biotech company moves to The Stiller Centre for Biotechnology.
August 2, 2004... 2004 AUG 2 - (NewsRx.com & NewsRx.net) -- Plantigen Inc. has moved to The Stiller Centre for Biotechnology. The company is the first spin-off of the Lawson Health Research Institute to mature into its own space. According to Mary Gardner,...

New contracts announced for biodefense-related contract work.
August 2, 2004... 2004 AUG 2 - (NewsRx.com & NewsRx.net) -- Commonwealth Biotechnologies, Inc., (NASDAQ SmallCap Market: CBTE) announced additional new biodefense related contract work. The new contracts total nearly $1.2 million and are with government and...

New health/pharmaceutical government staff directory launched.
August 2, 2004... 2004 AUG 2 - (NewsRx.com & NewsRx.net) -- Congressional Quarterly's CQ Press Division has launched a new directory for anyone involved in the health and pharmaceutical industries. The directory lists Municipal, State, Congressional and...

Nine of top ten pharmaceutical companies attend user conference.
August 2, 2004... 2004 AUG 2 - (NewsRx.com & NewsRx.net) -- IntelliChem, Inc., held its first global user meeting in New York City to discuss the most pressing issues facing pharmaceutical companies as they deploy intelligent electronic lab notebooks (i ELN)...

Pharmaceutical company announces E.U. regulatory approval for T-GO.
August 2, 2004... 2004 AUG 2 - (NewsRx.com & NewsRx.net) -- Sinclair Pharma plc (Sinclair) announced the receipt of E.U. regulatory approval as a medical device for a newly patented product, T-GO, a treatment for painful throat conditions such as pharyngitis....

Pharmaceutical company enters license agreement for SubQ aesthetic product.
August 2, 2004... 2004 AUG 2 - (NewsRx.com & NewsRx.net) -- Medicis (MRX) has entered into an exclusive license agreement with Q-Med AB to market, distribute, sell, and commercialize in the United States and Canada Q-Med's product currently known as SubQ, an...

Pharmaceutical company seeks new independent auditor.
August 2, 2004... 2004 AUG 2 - (NewsRx.com & NewsRx.net) -- KV Pharmaceutical Company (KVa/KVb) has filed a Form 8-K with the U.S. Securities and Exchange Commission notifying the Commission of the resignation of its independent auditor, BDO Seidman, LLP. ...

Pharmaceutical firm works to become advanced drug discovery chemistry provider.
August 2, 2004... 2004 AUG 2 - (NewsRx.com & NewsRx.net) -- AFID Therapeutics, Inc., announced the launch of the first phase of its campaign to establish itself as the provider of the most advanced drug discovery chemistry in the industry. An array of...

Prudencia selects online pharmacy for mail order services.
August 2, 2004... 2004 AUG 2 - (NewsRx.com & NewsRx.net) -- drugstore.com, inc., (Nasdaq:DSCM) announced that it will provide mail-order pharmacy services for Prudencia, Inc. In addition to the new arrangement with Prudencia, Inc., the drugstore.com...

Early stage cancers could be predicted with accuracy by confocal laser endoscopy.
August 2, 2004... 2004 AUG 2 - (NewsRx.com & NewsRx.net) -- The significance of cancer diagnosis trial results from the new flexible endo-microscope, jointly developed by Optiscan and Pentax, has been recognized by the prestigious international medical journal,...

Biopharmaceutical company announces promotion agreement for Kadian.
August 2, 2004... 2004 AUG 2 - (NewsRx.com & NewsRx.net) -- MGI Pharma, Inc., (MOGN) has entered into a 3-year agreement with Alpharma, Inc., to promote Alpharma's sustained release morphine sulfate product, Kadian. Under the terms of this promotion...

Catalytic antioxidant inhibits tumor regrowth following radiation therapy.
August 2, 2004... 2004 AUG 2 - (NewsRx.com & NewsRx.net) -- Incara Pharmaceuticals Corporation (ICRA) has announced further data that demonstrate that the administration of a compound, AEOL 10113, from the company's class of proprietary catalytic antioxidants...

DNABarrier cancer treatment licensed to Chinese biotechnology corporation.
August 2, 2004... 2004 AUG 2 - (NewsRx.com & NewsRx.net) -- Mologen announced licensing of its dSLIM-based DNABarrier II to the Chinese biotechnology corporation Starvax Inc. of Beijing, PR China. DNABarrier II is one of three applications currently under...

First batch of cGMP paclitaxel produced by manufacturer.
August 2, 2004... 2004 AUG 2 - (NewsRx.com & NewsRx.net) -- Bioxel Pharma, Inc., (BIP), a manufacturer of naturally derived taxanes and targeted oncology drugs, announced the release and sale of its first kilogram scale lots of cGMP paclitaxel from the new...

Nanomedicine global developments and growth opportunities explored.
August 2, 2004... 2004 AUG 2 - (NewsRx.com & NewsRx.net) -- The adoption of nanotechnology-based applications by large therapeutic and diagnostic companies is accelerating the development of nanomedicine. The prospect of site-specific therapeutic action and...

National Cancer Institute grant received to develop multiplex cell assay.
August 2, 2004... 2004 AUG 2 - (NewsRx.com & NewsRx.net) -- PharmaSeq announced the receipt of a Phase I SBIR grant from the U.S. National Cancer Institute, a branch of U.S. National Institutes of Health (NIH). The main goal of the research is to develop a...

Patent issued for method to predict effectiveness of chemotherapy.
August 2, 2004... 2004 AUG 2 - (NewsRx.com & NewsRx.net) -- U.S. Patent and Trademark Office granted patent gene methylation technology for the prediction of clinical response to certain types of chemotherapeutic treatment of cancer patients. The treatment...

Mechanism of benzene-induced leukemia elucidated.
August 2, 2004... 2004 AUG 2 - (NewsRx.com & NewsRx.net) -- The mechanism of benzene-induced leukemia has been elucidated. According to published research from the United States, "Acute myeloid leukemia and chronic lymphocytic leukemia are associated with...

AI-700 collaboration, license and supply agreement forged with Acusphere.
August 2, 2004... 2004 AUG 2 - (NewsRx.com & NewsRx.net) -- Nycomed announced that it has entered into a collaboration, license and supply agreement with Acusphere Inc. (NASDAQ: ACUS). The agreement grants Nycomed the rights to develop and market...

Prescriptions increase for cataplexy associated with narcolepsy.
August 2, 2004... 2004 AUG 2 - (NewsRx.com & NewsRx.net) -- Orphan Medical, Inc., (ORPH) announced that the total number of filled Xyrem (sodium oxybate) oral solution prescriptions in the 6-week period ended June 30, 2004, were 3425, up 16% over the prior...

OTC statin options discussed at inaugural meeting of Midwest Lipid Association.
August 2, 2004... 2004 AUG 2 - (NewsRx.com & NewsRx.net) -- The National Lipid Association (NLA) announced the inaugural meeting of the Midwest Lipid Association (MWLA). More than 100 lipid specialists primarily from around the Midwestern United States are...

Mechanisms of transition from acute to chronic muscle pain.
August 2, 2004... 2004 AUG 2 - (NewsRx.com & NewsRx.net) -- Certain mechanisms of transition occur from acute to chronic muscle pain. According to published research from Germany, "The present article presents an overview of neurophysiological and...

GMP approval granted by Belgium authorities for CellSpray manufacture.
August 2, 2004... 2004 AUG 2 - (NewsRx.com & NewsRx.net) -- Clinical Cell Culture, Ltd., (C3, CCE) announced that the Belgium Health Authorities have authorized Cambrex, C3's European contract manufacturer, to manufacture CellSpray and CellSpray XP on behalf of...

Endo Pharmaceuticals announces agreement for Oxymorphone ER trial design.
August 2, 2004... 2004 AUG 2 - (NewsRx.com & NewsRx.net) -- Penwest Pharmaceuticals Co. (NASDAQ:PPCO) announced that its development partner Endo Pharmaceuticals Holdings Inc. has reached agreement with the U.S. Food and Drug Administration (FDA) on the design...

Process uses riboflavin and light to reduce pathogens in donated blood.
August 2, 2004... 2004 AUG 2 - (NewsRx.com & NewsRx.net) -- Targeting the improved safety of transfusion medicine, the Mirasol PRT process uses riboflavin (also known as vitamin B2) and light to reduce the level of pathogens found in donated blood components,...

Agreement signed for Kadian in cancer pain.
August 2, 2004... 2004 AUG 2 - (NewsRx.com & NewsRx.net) -- Alpharma, Inc., (ALO) announced that it has entered into a 3-year agreement with MGI Pharma, Inc., an oncology focused biopharmaceutical company, for the promotion of Alpharma's Kadian product, a...

Agreement signed for glaucoma, ocular hypertension treatment.
August 2, 2004... 2004 AUG 2 - (NewsRx.com & NewsRx.net) -- R-Tech Ueno, Ltd., (headquartered Sanda, Hyogo, Japan) and Santen Pharmaceutical Co., Ltd., (headquartered Osaka, Japan) announced that Santen will acquire the exclusive marketing rights in Japan for...

Agreement signed with Artemis Pharmaceuticals for transgenic mice.
August 2, 2004... 2004 AUG 2 - (NewsRx.com & NewsRx.net) -- Biovitrum AB and Artemis Pharmaceuticals GmbH, Cologne, have signed a research services agreement concerning the generation of RNAi-modified transgenic mice for the in vivo functional analysis of...

Agreement with Nycomed for development of Oxygent terminated.
August 2, 2004... 2004 AUG 2 - (NewsRx.com & NewsRx.net) -- Alliance Pharmaceutical Corp. (ALLP) announced that Nycomed, its development partner for Oxygent in the European Union, has provided notice that it is terminating the recently announced license...

Alliance formed for point-of-care CD4 monitoring for HIV/AIDS patients.
August 2, 2004... 2004 AUG 2 - (NewsRx.com & NewsRx.net) -- Beckman Coulter, Inc., announced that it has entered into a strategic partnership agreement with PointCare Technologies, Inc. Under the terms of the agreement, Beckman Coulter has exclusive global...

Alliance signed to market, distribute cholesterol assay, nutrients.
August 2, 2004... 2004 AUG 2 - (NewsRx.com & NewsRx.net) -- Akers Biosciences, Inc., announced that the company has entered into a strategic alliance with Soft Gel Technologies, Inc., to market and distribute the company's Tri-Cholesterol rapid assay combined...

Companies agree to discontinue codevelopment of abciximab in Japan.
August 2, 2004... 2004 AUG 2 - (NewsRx.com & NewsRx.net) -- Fujisawa Pharmaceutical Co., Ltd., announced that Centocor, Inc., Nippon Centocor, KK, (a Japanese subsidiary of Centocor, Inc.), and Fujisawa have reached an agreement on the withdrawal of Fujisawa...

Exclusive license agreement signed to commercialize Tostrex gel in Europe.
August 2, 2004... 2004 AUG 2 - (NewsRx.com & NewsRx.net) -- Cellegy Pharmaceuticals, Inc., (CLGY) and Strakan Pharmaceuticals Limited announced that they have entered in to an exclusive license agreement for the future commercialization of Tostrex (testosterone...

Five-year agreement signed for manufacture of cell cassettes.
August 2, 2004... 2004 AUG 2 - (NewsRx.com & NewsRx.net) -- Moll Industries, Inc., a medical devices and components supplier, announced that a 5-year agreement was reached with Aastrom Biosciences, Inc., (ASTM) in first quarter 2004 continuing Moll as sole...

Genomics application licensed from Stanford University.
August 2, 2004... 2004 AUG 2 - (NewsRx.com & NewsRx.net) -- BioTrove, Inc., announced that the company has acquired an exclusive license from Stanford University for patent applications that cover the use of a through-hole structured microarray to perform PCR....

Microarray platform licensed to University of Nottingham.
August 2, 2004... 2004 AUG 2 - (NewsRx.com & NewsRx.net) -- PamGene International BV has announced the licensing of its 3-Dimensional, Flow-Through Microarray Platform to Nottingham University, England. This service license, which includes the sale of a...

Perrigo named as U.S. pharmaceutical firm in licensing agreement for Tabwrap.
August 2, 2004... 2004 AUG 2 - (NewsRx.com & NewsRx.net) -- BioProgress plc confirmed that Perrigo Company is the U.S. pharmaceutical company with which it has executed an exclusive licensing agreement for its Xgel Tabwrap dosage form. Perrigo has acquired...

Research deal signed to study epilepsy animal models.
August 2, 2004... 2004 AUG 2 - (NewsRx.com & NewsRx.net) -- Bionomics (BNO, BNOOA, BMICY) announced that they have entered into a research collaboration relating to the study of Bionomics' proprietary animal model of epilepsy with the University of Wisconsin...

Positive phase II study results reported for INKP-102 purgative product.
August 2, 2004... 2004 AUG 2 - (NewsRx.com & NewsRx.net) -- InKine Pharmaceutical Company, Inc., (INKP) announced the results of the company's multicenter phase II study of its next-generation sodium phosphate tablet, INKP-102, a purgative being developed for...

Bio-One says second quarter revenue to exceed $13 million.
August 2, 2004... 2004 AUG 2 - (NewsRx.com & NewsRx.net) -- Bio-One Corporation (BICO) announced that its revenue for the second fiscal quarter ended June 30, 2004, will exceed $13 million. The company said it expects operating profits to be approximately...

Doctors support pharmaceutical industry involvement in CME, survey shows.
August 2, 2004... 2004 AUG 2 - (NewsRx.com & NewsRx.net) -- The role of pharmaceutical and medical technology companies in supporting medical education conferences is well understood and accepted by an overwhelming majority of primary care physicians, the...

Protopic more effective for eczema in children than pimecrolimus.
August 2, 2004... 2004 AUG 2 - (NewsRx.com & NewsRx.net) -- Fujisawa's Protopic (tacrolimus ointment) is more effective across the symptom spectrum in the treatment of atopic dermatitis (AD, eczema) than pimecrolimus (Elidel, Novartis). These findings are...

Recruitment complete for Phase II trial of AVAC in childhood eczema.
August 2, 2004... 2004 AUG 2 - (NewsRx.com & NewsRx.net) -- Genesis Research and Development Corporation (NZX/ASX:GEN) announced that recruitment is complete for the Phase II trial of its childhood eczema therapeutic candidate, AVAC. The randomized,...

New classification of diabetic foot infections proposed.
August 2, 2004... 2004 AUG 2 - (NewsRx.com & NewsRx.net) -- Members of the Infectious Diseases Society of America have proposed a new classification of diabetic foot infections. "The treatment of diabetic foot ulcers is first determined by the presence or...

NeutroSpec approved by FDA.
August 2, 2004... 2004 AUG 2 - (NewsRx.com & NewsRx.net) -- Palatin Technologies, Inc., (AMEX:PTN) announced that it has received full approval from the U.S. Food and Drug Administration (FDA) to market NeutroSpec. NeutroSpec is a novel imaging agent,...

PA Secretary of Aging to serve on Medicare drug benefit commission.
August 2, 2004... 2004 AUG 2 - (NewsRx.com & NewsRx.net) -- Pennsylvania Secretary of Aging Nora Dowd Eisenhower has been appointed by the U.S. Department of Health and Human Services (HHS) to serve on the State Pharmaceutical Assistance Transition Commission, a...

Cepheid expands distribution in China.
August 2, 2004... 2004 AUG 2 - (NewsRx.com & NewsRx.net) -- Cepheid (CPHD) has executed a nonexclusive distribution agreement with Gene Co. for distribution of Cepheid's products in the clinical research and life sciences markets in China and Hong Kong. ...

Curacyte signs agreement for distribution of serine protease inhibitors.
August 2, 2004... 2004 AUG 2 - (NewsRx.com & NewsRx.net) -- Curacyte, AG, announced its wholly owned subsidiary, Curacyte Chemistry, GmbH, has entered into a distribution agreement with Haemochrom Diagnostica, GmbH, an Essen, Germany-based international...

Company to sell its holdings in Elbit Systems.
August 2, 2004... 2004 AUG 2 - (NewsRx.com & NewsRx.net) -- Elron Electronic Industries, Ltd., (ELRN) announced the signing of a definitive agreement for the sale of all of its holdings in Elbit Systems, Ltd., (ESLT), constituting approximately 19.6% of the...

Elan sells its Myobloc rights.
August 2, 2004... 2004 AUG 2 - (NewsRx.com & NewsRx.net) -- Elan Corp., plc, has completed the sale of its worldwide rights to Myobloc/Neurobloc (Myobloc) (Botulinum Toxin Type B) injectable solution to Solstice Neurosciences, Inc., (Solstice), a newly formed...

Company announces patent related to transdermal delivery of amine drugs.
August 2, 2004... 2004 AUG 2 - (NewsRx.com & NewsRx.net) -- Dermatrends, Inc., a drug-delivery company, has received a U.S. patent that covers the method of using bases to enhance the permeation of amine drugs across the skin. The patent is the 11th granted...